1% Propofol for
EMEA submission was successfully delivered using ICU setup.
We support pharmaceuticals to
Perform complex Bioequivalence studies with 100% regulatory approvals.
Complex first to file iron sucrose study
to USFDA for its client.
Australian authority accepted justification
and safety rational.
for change of salt from succinate to oxalate for desvelafaxine.